22.Issue 12 december 23 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 10, Issue : 12, December – 2023

Title:

AN OVERVIEW – RADIATION DOSE TO PATIENTS DURING SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)

Authors :

Ghadeer Hamzah Mohammed Najjar, Saadiah Hadi Mohammed Alhassani, Kholood QasemMokhtar Al Turkistani,Shimaa Abdulhakeem I Tujjralshahy,Saleh Ahmed Alzahrani,Rasha Mohammad Aletyani,Ikhlas Hasin Aljabry,Maysa Ehsan Taybe,Ahmad Adil Saggat,Abeer Abdulrahman Aladamawi,Anmar Esssam Koudwardia

Abstract :

The objective is to evaluate the radiation dosage received by the patient during regular clinical single-photon emission computed tomography-computed tomography (SPECT-CT) and quantify the increase in comparison to SPECT alone. Incorporating CT into nuclear medicine imaging, specifically in the form of SPECT-CT, results in an elevated radiation dose for the patient. In fact, the effective dose from CT often surpasses the effective dose from RP in numerous cases. Therefore, it is necessary to effectively employ and optimize the protocols of SPECT-CT in order to maximize the advantages for patients. Implementing a dose-tracking software provided a simple method for optimization. In addition, we can readily compute the primary dosimetric parameters and monitor their patterns on a daily basis to promptly implement any required corrective measures in real-time.

Cite This Article:

Please cite this article in press Ghadeer Hamzah Mohammed Najjar et al., An Overview – Radiation Dose To Patients During Single Photon Emission Computed Tomography (SPECT), Indo Am. J. P. Sci, 2023; 10 (12).

Number of Downloads : 10

References:

1. Beyer T, Freudenberg LS, Townsend DW, Czernin J. The future of hybrid imaging−part 1: hybrid imaging technologies and SPECT/CT. Insights Imaging 2011;2:161–9.
2. Beyer T, Townsend DW, Czernin J, Freudenberg LS. The future of hybrid imaging−part 2: PET/CT. Insights Imaging 2011;2: 225–34.
3. Hicks RJ, Hofman MS. Is there still a role for SPECT-CT in oncology in the PET-CT era? Nat Rev Clin Oncol 2012;9:712–20.
4. Wieder H, Freudenberg LS, Czernin J, Navar BN, Isral I, Beyer T. Variations of clinical SPECT/CT operations: an international survey. Nuklearmedizin 2012;51:154–60.
5. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 2007;168:1–64.
6. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington: National Academies Press; 2006.
7. Nosske D, Mattsson S, Johansson L. Dosimetry in nuclear medicine diagnosis and therapy. In: Kaul A, editor. Medical radiological phys- ics. Landold-Börnstein. New series, group VIII, vol 7A. Berlin: Springer; 2012. p. 4–1–4.59.
8. Hong H, Chen F, Zhang Y, Cai W. New radiotracers for imaging of vascular targets in angiogenesis-related diseases. Adv Drug Deliv Rev. 2014;76:2-20.
9. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine-applications of dual- modality systems in oncology. Cancer Biother Radiopharm. 2004;19(1):1-10.
10. Delbeke D, Schöder H, Martin WH, Wahl RL, editors. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med. 2009;39(5):308-40.
11. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging? Eur. J. Nucl. Med. Mol. Imaging. 2005;32(5):521-4.
12. Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011;52(2):210-7.
13. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485-507.
14. Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur. J. Nucl. Med. Mol. Imaging. 2015;42(12):1929-40.
15. Stabin M, Xu XG, editors. Basic principles in the radiation dosimetry of nuclear medicine. Seminars in nuclear medicine; Semin Nucl Med. 2014;44(3):162-71
16. Pourjabbar S, Singh S, Padole A, Saini A, Blake MA, Kalra MK. Size-specific dose estimates: Localizer or transverse abdominal computed tomography images? World J Radiol. 2014;6(5):210.
17. Wells RG. Dose reduction is good but it is image quality that matters. J Nucl Cardiol. July 24, 2018
18. Sharma P, Sharma S, Ballal S, Bal C, Malhotra A, Kumar R. SPECT-CT in routine clinical practice: increase in patient radiation dose compared with SPECT alone. Nucl Med Commun. 2012;33:926–932.
19. Larkin AM, Serulle Y, Wagner S, Noz ME, Friedman K. Quantifying the increase in radiation exposure associated with SPECT/CT compared to SPECT alone for routine nuclear medicine examinations. Int J Mol Imaging. 2011;2011:879202.
20. Andersson M, Johansson L, Minarik D, Leide-Svegborn S, Mattsson S. Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors. EJNMMI Phys. 2014;1:9.
21. Andersson M. Erratum to: effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors. EJNMMI Phys. 2015;2:22.
22. Tamam M, Mulazimoglu M, Edis N, Ozpacaci T. The value of attenuation correction in hybrid cardiac SPECT/CT on inferior wall according to body mass index. World J Nucl Med. 2016;15:18–23.
23. Apostolopoulos DJ, Savvopoulos C. What is the benefit of CT-based attenuation correction in myocardial perfusion SPET? Hell J Nucl Med. 2016;19:89–92.
24. Peli A, Camoni L, Zilioli V, et al. Attenuation correction in myocardial perfusion imaging affects the assessment of infarct size in women with previous inferior infarct. Nucl Med Commun. 2018;39:290–296.
25. Thompson RC. CT attenuation correction for thallium SPECT MPI and other benefits of multimodality imaging. J Nucl Cardiol. 2019;26:1596–1598.
26. Dorbala S, Ananthasubramanium K, Armstrong IS, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018;25:1784–1846.
27. Ghetti C, Ortenzia O, Palleri F, Sireus M. Definition of local diagnostic reference levels in a radiology department using a dose tracking software. Radiat Prot Dosimetry 2017; 175:38–45.
28. Verbene HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F,
De Bondt P, et al. EANM procedural guide lines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT. Available at: http://www. eanm.org/publications/guidelines/2015_07_EANM_FINAL_myocardial_ erfusion_guideline.pdf.
29. Abdollahi H, Shiri I, Salimi Y, Sarebani M, Mehdinia R, Deevband MR, et al. Radiation dose in cardiac SPECT/CT: an estimation of SSDE and effective dose. Eur J Radiol 2016; 85:2257–2261.
30. Iball GR, Bebbington NA, Burniston M, Edyvean S, Fraser L, Julyan P, et al. A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK. Nucl Med Commun 2017; 38:459–470.